Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2019-01-04 2019-01-04
Drug Identification Number 02290901 02290901
Brand name ACETAMINOPHEN HEADACHE ULTRA RELIEF ACETAMINOPHEN HEADACHE ULTRA RELIEF
Common or Proper name ACETAMINOPHEN/CAFFEINE TAB 500/65MG ACETAMINOPHEN/CAFFEINE TAB 500/65MG
Company Name APOTEX INC APOTEX INC
Ingredients ACETAMINOPHEN CAFFEINE ACETAMINOPHEN CAFFEINE
Strength(s) 500MG 65MG 500MG 65MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 20 BTL & 80 BTL 20 BTL & 80 BTL
ATC code N02BE N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS OTHER ANALGESICS AND ANTIPYRETICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-12-12 2017-12-12
Remaining supply date 2017-12-12 2017-12-12
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments